Does the size of response to cabozantinib plus nivolumab affect clinical outcomes?
Ongoing results from the phase 3 CheckMate-9ER clinical trial with [...]
Ongoing results from the phase 3 CheckMate-9ER clinical trial with [...]
Collecting duct carcinoma is a rare and aggressive form of [...]
This phase 1 clinical trial looked at the safety, tolerability, [...]
Results from a phase 2 study were presented at the [...]
Ongoing results from the phase 3 CheckMate-9ER clinical trial with nivolumab plus cabozantinib have been [...]
In a recent study, the use of cabozantinib after progression [...]
Brain metastases resulting from the spread of renal cell carcinoma [...]
The Scottish Medicines Consortium (SMC) has approved the use of [...]
This phase Ib study reports the results of a combination [...]
Kidney cancers frequently have mutations in the von Hippel-Lindau (VHL) [...]